The Australian Government is now in caretaker period. During this time, updates on this website will be published in accordance with the Guidance on Caretaker Conventions, until after the election.
732 results found
The 28th biannual report.
The 26th biannual report.
For the 30th anniversary of International Men’s Health Week (10–16 June 2024), NHMRC shined an important light on key issues impacting the health and wellbeing of Australian men and boys, focusing on the 3 pillars of health: physical, mental and emotional.
The 30th biannual report.
The 29th biannual report
NHMRC recognises excellence in the health and medical research sector through its annual Research Excellence Awards. Find our 2024 award winners listed below.
The Embryo Research Licensing Committee (ERLC) maintains an online database of general and mitochondrial donation licences.
The United Nations (UN) International Day of Persons with Disabilities promotes community awareness, understanding and acceptance of the estimated 1.3 billion people with disability worldwide and to celebrate their achievements.
At the request of the Minister for Health and Aged Care, the National Health and Medical Research Council has undertaken a review of gain-of-function research in Australia. The Executive Summary from the review report, and a copy of the full report, is available below.
The Statement on consumer and community involvement in health and medical research (The Statement), co-authored by the National Health and Medical Research Council (NHMRC) and the Consumers Health Forum of Australia (CHF), aims to guide research institutions, researchers, consumers and community members in the active involvement of consumers and community members in all aspects of health and medical research.
Keeping research on track II was developed to provide advice on how the values and principles outlined in Ethical conduct in research with Aboriginal and Torres Strait Islander Peoples and communities: Guidelines for researchers and stakeholders can be put into practice in research.
The NHMRC Corporate Plan 2024-25 presents our strategy for building a healthy Australia, across the strategic themes (purposes) of investment, translation and integrity of health and medical research. The plan also includes our strategic and health priorities, as well as our key activities planned for 2024–25 and over the next few years. The plan describes the operating context in which we work and outlines our performance criteria and targets for the next 4 years.
In conjunction with the Australian Clinical Trials Alliance, we developed the clinical trials competencies to be used in the development of detailed curricula and training courses by universities, Colleges and other registered training organisations*.
The NHMRC Corporate Plan 2020-21 covers the four years to 2023-24. In line with legislated requirements, it identifies major health issues likely to arise, how NHMRC will deal with these issues (including the continuing impact of COVID-19) and our strategy for health and medical research. It also details the key activities NHMRC will undertake to achieve our purposes, and the operating context in which we work, comprising: environment, capability, risk oversight and management, and organisations NHMRC cooperates with to achieve our purposes.